Spectral-domain Optical Coherence Tomography Characteristics of Intermediate Age-related Macular Degeneration

Overview

Journal Ophthalmology

Publisher Elsevier

Specialty Ophthalmology

Date 2012 Sep 13

PMID 22968145

Citations 54

Authors

Jessica N Leuschen

Stefanie G Schuman

Katrina P Winter

Michelle N McCall

Wai T Wong

Emily Y Chew

Thomas Hwang

Sunil Srivastava

Neeru Sarin

Traci Clemons

Molly Harrington

Cynthia A Toth

Affiliations

Soon will be listed here.

Abstract

Purpose: Describe qualitative spectral-domain optical coherence tomography (SD-OCT) characteristics of eyes classified as intermediate age-related macular degeneration (nonadvanced AMD) from Age-Related Eye Disease Study 2 (AREDS2) color fundus photography (CFP) grading.

Design: Prospective cross-sectional study.

Participants: We included 345 AREDS2 participants from 4 study centers and 122 control participants who lack CFP features of intermediate AMD.

Methods: Both eyes were imaged with SD-OCT and CFP. The SD-OCT macular volume scans were graded for the presence of 5 retinal, 5 subretinal, and 4 drusen characteristics. In all, 314 AREDS2 participants with ≥1 category-3 AMD eye and all controls each had 1 eye entered into SD-OCT analysis, with 63 eyes regraded to test reproducibility.

Main Outcome Measures: We assessed SD-OCT characteristics at baseline.

Results: In 98% of AMD eyes, SD-OCT grading of all characteristics was successful, detecting drusen in 99.7%, retinal pigment epithelium (RPE) atrophy/absence in 22.9%, subfoveal geographic atrophy in 2.5%, and fluid in or under the retina in 25.5%. Twenty-eight percent of AMD eyes had characteristics of possible advanced AMD on SD-OCT. Two percent of control eyes had drusen on SD-OCT. Vision loss was not correlated with foveal drusen alone, but with foveal drusen that were associated with other foveal pathology and with overlying focal hyperreflectivity. Focal hyperreflectivity over drusen, drusen cores, and hyper- or hyporeflectivity of drusen were also associated with RPE atrophy.

Conclusions: Macular pathologies in AMD can be qualitatively and reproducibly evaluated with SD-OCT, identifying pathologic features that are associated with vision loss, RPE atrophy, and even possibly the presence of advanced AMD not apparent on CFP. Qualitative and detailed SD-OCT analysis can contribute to the anatomic characterization of AMD in clinical studies of vision loss and disease progression.

Financial Disclosure(s): Proprietary or commercial disclosure may be found after the references.

Citing Articles

Artificial intelligence in managing retinal disease-current concepts and relevant aspects for health care providers.

Riedl S, Birner K, Schmidt-Erfurth U Wien Med Wochenschr. 2025; .

PMID: 39992600 DOI: 10.1007/s10354-024-01069-1.

Deep-Reticular Pseudodrusen-Net: A 3-Dimensional Deep Network for Detection of Reticular Pseudodrusen on OCT Scans.

Elsawy A, Keenan T, Thavikulwat A, Lu A, Bellur S, Mukherjee S Ophthalmol Sci. 2025; 5(2):100655.

PMID: 39866344 PMC: 11758204. DOI: 10.1016/j.xops.2024.100655.

Current advances in multimodal imaging in geographic atrophy secondary to age-related macular degeneration: A review.

Cohn A, Guymer R Taiwan J Ophthalmol. 2025; 14(4):464-472.

PMID: 39803396 PMC: 11717336. DOI: 10.4103/tjo.TJO-D-24-00065.

Topographical Quantification of Hyper-Reflective Foci May Predict the Development of Macular Atrophy in Patients With Neovascular Age-Related Macular Degeneration.

Viggiano P, Boscia G, Giannaccare G, Santoro M, Petrara G, Borriello C Invest Ophthalmol Vis Sci. 2024; 65(14):45.

PMID: 39739348 PMC: 11687154. DOI: 10.1167/iovs.65.14.45.

Analysis of factors affecting prognosis of the visual acuity and baseline risk factors for subretinal fibrosis in neovascular age-related macular degeneration patients.

Liu S, Zheng M, Sun H, Pan C, Li D, Zhou X Front Med (Lausanne). 2024; 11:1451726.

PMID: 39669991 PMC: 11634580. DOI: 10.3389/fmed.2024.1451726.

References

Schuman S, Koreishi A, Farsiu S, Jung S, Izatt J, Toth C . Photoreceptor layer thinning over drusen in eyes with age-related macular degeneration imaged in vivo with spectral-domain optical coherence tomography. Ophthalmology. 2009; 116(3):488-496.e2. PMC: 2695995. DOI: 10.1016/j.ophtha.2008.10.006. View

Williams M, Craig D, Passmore P, Silvestri G . Retinal drusen: harbingers of age, safe havens for trouble. Age Ageing. 2009; 38(6):648-54. DOI: 10.1093/ageing/afp136. View

Ferris F, Davis M, Clemons T, Lee L, Chew E, Lindblad A . A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol. 2005; 123(11):1570-4. PMC: 1473206. DOI: 10.1001/archopht.123.11.1570. View

Drexler W, Sattmann H, Hermann B, Ko T, Stur M, Unterhuber A . Enhanced visualization of macular pathology with the use of ultrahigh-resolution optical coherence tomography. Arch Ophthalmol. 2003; 121(5):695-706. DOI: 10.1001/archopht.121.5.695. View

Yehoshua Z, Wang F, Rosenfeld P, Penha F, Feuer W, Gregori G . Natural history of drusen morphology in age-related macular degeneration using spectral domain optical coherence tomography. Ophthalmology. 2011; 118(12):2434-41. PMC: 3189426. DOI: 10.1016/j.ophtha.2011.05.008. View

Friedman D, OColmain B, Munoz B, Tomany S, McCarty C, de Jong P . Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004; 122(4):564-72. DOI: 10.1001/archopht.122.4.564. View

Huang D, Swanson E, Lin C, Schuman J, Stinson W, Chang W . Optical coherence tomography. Science. 1991; 254(5035):1178-81. PMC: 4638169. DOI: 10.1126/science.1957169. View

Gupta N, Brown K, Milam A . Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration. Exp Eye Res. 2003; 76(4):463-71. DOI: 10.1016/s0014-4835(02)00332-9. View

Ma W, Zhao L, Fontainhas A, Fariss R, Wong W . Microglia in the mouse retina alter the structure and function of retinal pigmented epithelial cells: a potential cellular interaction relevant to AMD. PLoS One. 2009; 4(11):e7945. PMC: 2775955. DOI: 10.1371/journal.pone.0007945. View

10.

Klein R, Wang Q, Klein B, Moss S, Meuer S . The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci. 1995; 36(1):182-91. View

11.

Klein R, Klein B, Knudtson M, Meuer S, Swift M, Gangnon R . Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology. 2007; 114(2):253-62. DOI: 10.1016/j.ophtha.2006.10.040. View

12.

Toth C, Narayan D, Boppart S, Hee M, Fujimoto J, Birngruber R . A comparison of retinal morphology viewed by optical coherence tomography and by light microscopy. Arch Ophthalmol. 1997; 115(11):1425-8. DOI: 10.1001/archopht.1997.01100160595012. View

13.

Wang J, Rochtchina E, Lee A, Chia E, Smith W, Cumming R . Ten-year incidence and progression of age-related maculopathy: the blue Mountains Eye Study. Ophthalmology. 2007; 114(1):92-8. DOI: 10.1016/j.ophtha.2006.07.017. View

14.

Sunness J, Margalit E, Srikumaran D, Applegate C, Tian Y, Perry D . The long-term natural history of geographic atrophy from age-related macular degeneration: enlargement of atrophy and implications for interventional clinical trials. Ophthalmology. 2007; 114(2):271-7. PMC: 2562326. DOI: 10.1016/j.ophtha.2006.09.016. View

15.

Iwama D, Tsujikawa A, Ojima Y, Nakanishi H, Yamashiro K, Tamura H . Relationship between retinal sensitivity and morphologic changes in eyes with confluent soft drusen. Clin Exp Ophthalmol. 2010; 38(5):483-8. DOI: 10.1111/j.1442-9071.2010.02294.x. View

16.

Hee M, Baumal C, Puliafito C, Duker J, Reichel E, WILKINS J . Optical coherence tomography of age-related macular degeneration and choroidal neovascularization. Ophthalmology. 1996; 103(8):1260-70. DOI: 10.1016/s0161-6420(96)30512-5. View

17.

Klein R, Davis M, Magli Y, Segal P, Klein B, Hubbard L . The Wisconsin age-related maculopathy grading system. Ophthalmology. 1991; 98(7):1128-34. DOI: 10.1016/s0161-6420(91)32186-9. View

18.

Maguire M, Alexander J, Fine S . Characteristics of choroidal neovascularization in the complications of age-related macular degeneration prevention trial. Ophthalmology. 2008; 115(9):1468-73, 1473.e1-2. DOI: 10.1016/j.ophtha.2008.02.028. View

19.

Davis M, Gangnon R, Lee L, Hubbard L, Klein B, Klein R . The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol. 2005; 123(11):1484-98. PMC: 1472813. DOI: 10.1001/archopht.123.11.1484. View

20.

Srinivasan V, Wojtkowski M, Witkin A, Duker J, Ko T, Carvalho M . High-definition and 3-dimensional imaging of macular pathologies with high-speed ultrahigh-resolution optical coherence tomography. Ophthalmology. 2006; 113(11):2054.e1-14. PMC: 1939823. DOI: 10.1016/j.ophtha.2006.05.046. View